Hypertension Resistant to Conventional Therapy clinical trials

The registry lists 47 studies for Hypertension Resistant to Conventional Therapy across more than 10 countries. 3 are recruiting or about to start. 43 of them are mainly about Hypertension Resistant to Conventional Therapy (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Hypertension Resistant to Conventional Therapy studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 21
Status unknown: 13
Terminated: 7
Active, not recruiting: 2
Recruiting: 2
Not yet recruiting: 1

Phase

Phase 4: 7
Phase 2: 5
Phase 1: 3
Phase 3: 2
Early Phase 1: 1

Where

France: 6
United States: 6
Germany: 6
Brazil: 5
China: 5
Belgium: 4

Who runs them

BackBeat Medical Inc (4) · Assistance Publique - Hôpitaux de Paris (2) · University of Cambridge (2) · University Hospital, Grenoble (2) · Macmillan Research Group UK (1) · Charite University, Berlin, Germany (1) · Tomsk National Research Medical Center of the Russian Academy of Sciences (1) · Cardiovascular Center Frankfurt (1)

What is being tested here

Drugs under test in Hypertension Resistant to Conventional Therapy studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Minocycline	1	0	1
Spironolactone	0	1	4
Furosemide	0	0	1
Amiloride	0	0	1
Enalapril	0	0	1
Lisinopril	0	0	1
Bisoprolol	0	0	1
Doxazosin	0	0	1
Losartan	0	0	1
Hydrochlorothiazide	0	0	1

Drug classes tested here Diuretics 5

Who these studies take

Of the 2 Hypertension Resistant to Conventional Therapy studies recruiting now, 0 (0%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (50%) take healthy volunteers.

Recruiting studies that take each age, of 2
Age	Women	Men
10	0 (0%)	0 (0%)
18	2 (100%)	2 (100%)
30	2 (100%)	2 (100%)
40	2 (100%)	2 (100%)
50	2 (100%)	2 (100%)
65	2 (100%)	2 (100%)
75	2 (100%)	2 (100%)
85	1 (50%)	1 (50%)

Across all 47 studies, recruiting or not: 36% stop at 75 or younger and 9% at 65; 0% take children; 0% are for women only and 0% for men only; 11% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 15, 2026.

Stopped1

Baroloop Multicenter Trial (Baroloop MCT)TerminatedOct 20, 2026NCT06518915

Studies

Recruiting first, then most recently updated. Showing 47 of 47. search them.